>brasilicardin_a_1
QRYALTDVSRGLIGEAGAARRAWMDLSGPGARMDAAYGGLAHALRTGGDGYSAVHGRPLWEDLADKPRLRAEFDTLMGTDTATVAHLVATEYDWTGIEHVIDVGGGAGILLTEILRARPSMRGTVVDLPRAVDTARQRFAAAGLGARADAIGGSFFEPLPAGADAYIVSRVLTDWNDQAAHDILRNCVAAARPGGRVLIVEVLPDDSVLAPDSPYDLQMLAVVGGRLRDADQFTALA
>APE_ec_1
IYYLAKIGHYLLHDTMTRVNMDFTQDVCYQGLFFLADSLNEGKPSGLKVFGDWPTIYPALSQLPDAARDSWFAFDHYYSDGAFNAALPYVFANNPTTLYDVGGNTGKWALRCCKFNENIAVTLLDLPQQIVLAKENIANAGFSDRIDFHAVDMLSDAPLPGEADIWWMSQFLDCFSPEQIISILSKIASVMKPGAKLCIMELFWDAQRFEATSFSLNASSLYFTCMANGNSR
>reductasporine_1
GAYANTPATAQYLVRGKSAYLGGLLEMSDARMYELWGRLDEGLRTGNPQNEIRTGEEGIYATLYDDPDRLDAFQQAMTGLSMRSAHALAEAIDWSAYRTVADIGCAEGTVLIHLLERHPHLRGTGFDLAAVRPSFQRRHEESGLGDRLAFRAGDFFAEPLPQADALVFGHILSNWALPKAKTLLRKAHEALPEGGIVVIYETLIDDERRENVPGLLMSLTMLLETPGGFEYTGADCREWL
>daunorubicin_1
TGERVLDIGCGRGACLFPAAEKVGSQGCVHGIDIAPGMIEEARKEATERGLRNISLMVMDAETPGFPARSFDLVMGS
>ristomycin_1
DYVNHPVATELLATTGPESWQHILLSWKTIYYPAFARMTSALRAGTNEALDALEGPGDTLYARLGNDPEKARIFYTAMSAFSLQTMPGLLEHIDVKSSRHLLDVGGGDGTTAAALLKANPGLKATLLDLASSVALAEQRVPAEVTDRLTLHPADLLTDPFPSGTDHALFSHVLDTFTAEQCVMLLAKAYEVLPSGGKISIYGFAAADDETGGPLSARLSLYLNILATGRGMAWPQAEAAAWL
>incednine_1
TSSSTLPGLVVRMLEDLAPKSGDRVLEIGTGTGYSTALMCHRLGDDHVTSIEYDPATAARARTAITKAGYAPRLLLGDGLLGDEQGAPYDQLIATCSVRTIPPAWLRQVKPGGTILTTV
>incednine_2
DRVLEIGTGTGYSTALMCHRLGDDHVTSIEYDPATAARARTAITKAGYAPRL
>incednine_3
EVSLREDPLLAELRRETAALPGGAAMQLMAEEGQLLGLLAGLVGARTVVEIGTFTGYSTLCLARALPADGRLITCDISPRWPRIGRPYWERAGVADRIEVAVGDAGDTLARLLGELGPASVDLVFIDADKTGYPRYYEDSLPLVRPGGLIAVDNTLFFGRVIDPEAVDADTEAIRKLNESLRDDERIDLSLLPFADGLTLARKR
>dutomycin_1
DGRQFALTPIAEGLRTDLPDGVRDAVLLDGSGFFWGSFGSILHSARTGHPGFDAANGMSFWEYLQANPEAGEVFDDAMTTISRRLGGLYLDRVDFSRFPVLADVGGGRGYFLAEILRRNPGIRGVLFDRPQVTDTAGELLGEREVAERVDVVGGDFFTDPIPAGCDAYVLKTVLHDWPDEKAVQILRRVREAIGDSAGRLLVLEQVVAPGNTWDTAKFLDVDMLVVMGGRERNLDEWRELF
>dutomycin_2
QGDRYAHTPVSRLLRTDTPRSLRDMVLWATEPWTWDVWPHLADAVRTGKGGFSEAHGKDFFTYLYEDAPESAEVFNRAMTQASRLSSAAIAESLDLRGDLTVVDVAGGHGDLIATVLERDPSLQGALFDLPGVLPDVDPRLREGGALHDRCQLVAGDCRDSVQVEADVFILKNVLEWDDAGTVAALRNVAASARPGGRVVVIENLVDGSPETGFTTAMDLLLLLNVDGRKHLRQS
>distamycin_1
DICQAAPGSVVVDVGCGSGLATRLLLERFAHVGSIVGVDPSEHELAIARKRLRDPKV
>arixanthomycin_1
GRFGLTPEAEPLRSDLDSSLRDLVRFSGDPLLTAPYANLALSVRTGKPAFDQVYGASFYDHVEAVPEDAVLFDRTMTQRSWLTAVTLLRRVDLSRFSRIADLGGGQGHFLGEALTKHYQDATALLFERPTVLARAKPLLAEYGVTDRVSLEAGDFFSEVPVGYDAYILNAVLNGLDDEQSKQVLARVRDAIGTDTEARLFIFEKVMTESVNAWDYSKLLDMDMLVLFGGRERTLSDWRELT
>arixanthomycin_2
DRFAESAMTPLLRSGRRSLVSFVLSFTGPGLYRPLEQLHNVVLEGHEHTERTLGKGLWDYYKENDEESTWFADTMGEQSEFAADILIPRVNFTDTKRIVDVGGSHGVLLSRVLEAHPHTSGVLFDLPEVVERAKDYIAERGLTDRVEFVPGSFLEELPAGGDLYLLKSILCDWDDDSCVRVLSNFRAAAAPGTPLVVSDWLLPEKPDLFLDITNIGLLAYTNGQVRNESQYRELF
>arixanthomycin_3
HYRNAPVTGQFLDRAKPSYSGGFLERANQVLYPAWTHLTDALRTGEQQARHVAADDLFDTPYQDQERVEAFLTMMDSLTSAIGPRLAQAFDWSSVATVVDVGGARGNLLSFLLRAHEHLTGTVFDLAPLREPAARLAEQHGLTGRLGFAAGSFFEDPVPPADVLVIGHVLHDWAPDERQQIVDRAFAAVEPGGSVLVYDCMLGEDDLDIARLTISIHMKLMTPGGAEYLVAE
>pristinamycin_1
EHARPQPGQRLLDVGCGLGATLLPAADRIGPTGHALGIDIAEAMIEQAGQEARRQGIDNVELRVMDGEHPDLPARSFDLV
>arenimycin_1
DGDHYRNSPLADQFLDRTKPTSIVGFAEMTSDTFYPAWGRFTKALRTGQAQAPLPPDDDQHLFRVNAVQEPDRVRRFMTAMDSHSTRMGEELANRIDWSGYQTVADLGGARGNLAAVIAKAHPHLKGICFDRPQSRPFFDEHIGRLGLTDRVVFEAGDFFSDDLPEVDVLIYGHVLHDWGPEARAGLLGRAYQRLRPGGALIIYDRMIDGSPEDLTRLFYSLTFMLASAGGSEYSVEECTDWL
>arenimycin_2
RPGERVLDVGCGRGSCLFPARDGVGPTGEVVGIDISAEMVRLTGAEALRRGHTNVTVQVMDGENPRFPRDHFDLVVAGFSIMHMPHAPAVLAEYLPLLKPGGRF
>oxytetracycline_1
GRFEHTDASRLLREDAPRGLRYSALWATEPWTWALWPHLADAVRTGREEFTALYGTEFFDWLHTAEARESAEVFDKAMTQSSVLSAKAIAEVLDLDGVGAMVDIAGGQGMVLATLLEKYPALRGTLFDLPKVVADADPRLREGGALAGRAQLVGGDCRQSVPEGADLYLLKNILEWDDESTVRTLRNVAKSAPAGARVVVVENLVDGSPETRFTTAMDLMLLLNVGGKKHTKAGLSALV
>oxytetracycline_2
DGDRYRNSPAAQAFLVSGASEYLGGTVLQHARKHYHVWAGLTTALQEGEAGSGAEAHGPEAYPKHYEDPERARQVMAHFDTFSSFTAEELARRVDWSGYGSFIDIGGARGNLATRVALAHPHLHGAVFDLPALAPLAGELIRERGLEGRVRFHGGDFLTDPLPSADAVVTGHVLPDWPVPQRRKLLARIHEALPSGGALVVYDLMTDPATTT
>dactylocycline_1
RDGERYRNSPTAAEFLVQDRPAYLGGTARQHAKLHYHAWGKLADAMREGRAQSAVAAQGAKAYVNYYEDLGQARRVMTHMDAHNGFTADEIARQLDWRGYATVTDVGGARGNVAARIVQAVPHLRANVVDLPALRPLFDELMAQLGTAGQVEFHGGDFFADPIPESDVIVVGHVLADWPQPRRVELLRRCHAALRPGGTVVVYDVMVDDDRDDVEALLQRLN
>dactylocycline_2
GRWAHTPMSRLLRDDAPLGLRHSVLWATEPWTWQLWPHLEQAVRSGHSVFEDLHGQEFFAYLHAEAPQSAEVFNRAMTQSSRLSGRAIADVLDLGDAEVVADIAGGQGHVLRTLLERHTHLRGVLFDLPEVVAAADPVLRPGGALAGRVRLVAGDCRHDVPVRADVYLLKNILEWDDDSTVATLRGIVAAARPGARVMVLENLIDGSPEMRFTTAMDLLLLLNVGGRKHTRQG
>lymphostin_2_1
QIIFHPLGKMVADLLELKPGERVLDLGCGRGACLFPVAAQVGTDGFVLGIDQAPGMVDACGADIEARGLADRAQVRLGDAQN
>lymphostin_2_2
LGKMVADLLELKPGERVLDLGCGRGACLFPVAAQVGTDGFVLGIDQAPGMVDACGADIEARGLADRAQVRLGDAQNFTVDQPFDALSAGMVLFLLPE
>A_74528_1
DGRYALTGIGEALRSDVPGSQRDMVLYNGDEMLWRSYGRLMHTVRTGEPAFEAAYGHGFFEHLEKNPESGALFDRAMTGMSRTTARMLLDGFDFGRFRRIADIGGGRGWFLAEILKAHPGVSGTLVDRPSVVEEATALFGDAGVADRVEIVPGDFFGELPPGRDAYVLKAVLHDWDDTKAVAILRRVREALDGSADGRLLICEFLVGPANQWDRGKLLDLDMLIRFGGRERGEDQWRELL
>geldanamycin_2_1
ELSLRDDEVLAGLRAETAGLPAAQAMQVMPEEGQLLGLLVRLVGARSVLEIGTFTGYSTLCMARALPADGTLITCDITEKWPGLGRPFWERAEVADRIDVRIGDAKDTLAGLRRAGREFDLVFIDADKTGYAHYYEESLAMLRRGGLIVLDNTLFFGRVTDPAAQDADTAALREMNKLLREDGRVEISMLTVGDGITLAVK
>d_cycloserine_1
NMIRTFAELVRATGNTRVADVGCGPGHLTAMLHDLGLDAFGLDLSPGMVAHARRAHPELRFDEARMEELPVEDGALGGVLAHYSAIHTPPQELPALLAEQARVLAPGGLLLV
>monensin_1
QMTDEMIRRLDPAPGDRVLDIGCGNGTPAMQLARARDVEVVGISVSARQVERGNRRAREAGLADRVRFEQVD
>cystobactamide_1
ELFFLTREMALFLDKKSPGYLGGSIDFLLSPYIMDGFKDLASVVRTGELTLPEKGVVAPDHPQWVTFARAMAPMMSLPSLLLAELADRQANQPLKVLDVAAGHGLFGLAIAQRNPKAHVTFLDWENVLQVARENATKAGVLDRVEFRPGDAFSVDFGKELDVILLTNFLHHFDEAGCEKILKKAHAALKEGGRVLTFEFIANEDRTSPPLAATFSMMMLGTTPGGETYAYSDLERMF
>nemadectin_1
RPVRRVLDVGCGSGRPALRLAHSEPVDIVGITISPRQVELATALAERSGLANRVRFECADAMDLPFPDASFDAVWALECLLHMPDPARVFQEMARVLRPGGRLA
>stambomycin_1
TSLVRERLPEADSLLDVACGSGDHLARFAASFGHVEGLDLSEDMVQLARRNTGVPVHRGDMRD
>dihyrdochalcomycin_1
QTRELYVDLIKRVVTNTVYGDHPTFPVGMNVLDKDLADSMRPDAPGSAVDHGRFDAGHRAEGLDVPTVAHTMIGLHRLDNIQKCVEQVLRDGVPGDFIETGVWRGGACILMRALLKAHGVEDRNVWLADSFAGVPVTSEDSHPLDQAMEFHNLNWVLSCSEEQVRQNVARYGLLDDQVKFLPGMFADTLPNAPIDQLAVLRLDGDLYESTMDALVNLYPKVSVGGFVIVDDYLIPACKQAVHDYRNEHGIDEPIETVDVTGVYWRR
>dihyrdochalcomycin_2
DADLYLDLLKKVVTNMIYEDQTNVAGLITSSSYSAELRAVGEDFPHVAHTMVGLKRLDNLQKCLEDVLRDGVPGDFAETGVWRGGACIFARGVFQAHGVRDRKVWVADSFQGFPKTTEDDHQLDVDIDLGQYNEVLSIPVDVETVKRNFARYGLLDDQVRFLPGWFKDTMPTAPIEKLAVLRLDGDSYAATREVLTSLYHKVSVGGYVIVDDYCIPACRQAVHEFRDEHGITDEIHQIDRQGSYWRRS
>dihyrdochalcomycin_3
IVDIGGGTGHYHAKVVDAFPDVDGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLQDA
>tautomycin_1
ATSLRDDQVLAGLRAETATVPAAQALQVMPEEGQLLALLVGLTGARAVLEIGTFTGYSTLCMARALPTDGRLVTCDIAAKWPDMGRPFWEKAGVADLIEVRVGDARATLAALREEGAEFDFVFVDADKSGYLHYYEESLPLLRPGGLIVVDNTLFFGRVADPAVTDIDTVSVRELNTRLHTDERVEICLLPMADGITLVRKK
>tautomycin_2
LLVGLTGARAVLEIGTFTGYSTLCMARALPTDGRLVTCDIAAKWPDMGRPFWEKAGVADLIEVRVGDARATLAALREEGAEFDFVFVDA
>K_252a_2_1
RLVELLGIEKGQQILDVGCGRGAVTFPLAEAVGPTGRVFGIDLSAGMVEALRASVAAAGVPNIEVRHMDGQRPGFEPREFDAITGSMSI
>dehydrophos_1
AEMIAEAGRHGLDNVEFRQQDLFDWTPDRQWDAVFFAHWLAHVPDDRFEAFWESVRSAVAPGGVVEFVDVTDHERRLEQQ
>lomaiviticin_1
EFALNEAARSLLRSGRLHGLALDGHGGRSAAAWSGLLATVRTGQPGYQTVFGRSYWADLDADADLSASYDANMGRHAGEASDPAVLLDDAWTQVGHVVDVGGGTGETLAEILRARPTVRGTLIDLPRTVARSTEVFAAAGVADRVAVQGQSFFDPLPAGADVYLLKRLLLDWPDEQAVALLTRCAEAAAPDGRVVVVGGVSPGRSAASAGLLMMVQTGGKPRTLDEFRDLA
>nogalamycin_1
RPGQRVLDVGCGRGACLFPAARRVAPDGYALGIDIAPAMVEEAAAEAERLGMPHVEVRVMDGERPALPERSFERVLGSYSVIFFPEAL
>abyssomicin_1
ETVHRSAPESIRRELAALQVRAGDRVLEIGTGSGYSGALLAHLCCPDGQVTSIDISDELVRRAAAIHAERGVTSVDCHVGDGLAGYPAAAPFHRAVSWCAPPRLPRAWTQQVVNGGRIVA
>abyssomicin_2
VRAGDRVLEIGTGSGYSGALLAHLCCPDGQVTSIDISDELVRRAAAIHAERGVTSVDCHVGD
>chartreusin_2_1
LVELAAPQPGERVLDVGCGRGAALFPAARAVGPTGRAVGIDIADTMIEAARAEAARAGAENVELLVMDA
>himastatin_1
DRFSLTEFGGRLRSGTPDSERDDIMLSTAPELWAAWGELTAVVRSGEPARAPGTGRTAYEAMQEQPEVSAKLRAGMAQASALFATGVAEAYDFSRFRTVVDYGGDEGTLIAAVLTAAPDLRAVLYDRPEALERSTATLSAAGVADRCEVVEGDLTSPPPSGADACVLNNIVRDRGDEKATELLRSLRAGLAPTGRILLVETLMPPVLTPDESAAYGLTDLNNLVFAGGRERTRDEYAALL
>mycinamicin_1
GVELYLDLLKRTVSNFIYQDATHVAGLITEAAFVEEARESGEDYPTVAHTMIGMKRLNNLQHCVESALRDGVPGDVLETGVWRGGACIFARGILKAYDVRDRTVWVADSFQGFPKITDDDHPMDAEMNLHQYNEAVDLPTSLATVQRNFSRYGLLDDQVRFLPGWFKDTMPTAPFERLAVLRMDGDSYGATMDVLTHAYPRLSPGGFAIIDDYCIPACREAVHEYRDRHGISDEIVEIDRQGVYWR
>meilingmycin_1
AGRRVLDVGCGSGRPTVRLAQRAPTEVVGVTVSPVQIERATALAEREGVADRVRFIRADAMALPFPDASFDAVWALECMFHMPSPAQVLGEIARVLRPGGRLA
>novobiocin_1
NSDSSLYLDLMIKVLAGTVYEDPAHRENFSHRDSTYREEVRNEGRDWPANAHTMIGIKRLENIRQCVEDVIGNNVPGDLVETGVWRGGACILMRGILRAHDVRDRTVWVADSFQGIPDVGEDGYAGDRKMALHRRNSVLAVSEEEVRRNFRNYDLLDEQVRFLPGWFKDTLPTAPIDTLAVLRMDGDLYESTWDTLTNLYPKVSVGGYVIVDDYMMCPPCKDAVDEYRAKFDIADELITIDRDGVYWQRT
>saframycin_a_1
GRYQLATVLAELLKTDDWQRFKDTVGFEQYVCYEGQIDFTESLRSNSNVGLRRVRGSGRDLYHRLHENPQMEQAFYKYMRSWSELANQHLVEVLDLSGTSKLLDCGGGDAVNSIALAQANPHIEAGILEIPPTAPLTEKKIAEAGLSDRITVKPGDMHTDEFPTGYDTVMFAHQLVIWTPEENTALLRKAYNALPEGGRVIIFNSMSNDEGDGPVVA
>saframycin_a_2
EQVYSLTPLGEALTSGHPASALPSATLVAGQFGAAWGDLLETVRTGQSPFERSRGVSLFTHMEQDEELRAVFDDSQGRGLALELDEILRAIDFSAYPTVVDVGGSDGTFLRRILSAHPDISGIVFDLPGSTSLQAERPTADPLEGRYSVATGDFFDSLPEGGDLYLLSHILHDWDDDRAVQILRTCRAAMSDDATLMVVDLIAANRGQRDERLHTAALMDLYMLSLFGGNGGQERTAAQVEVLL
>staurosporine_2_1
LVAERLALRPGRHLLDVGCGIGVPALRIAGAHGVRVTGVTVSTQQVAEATRRADRSGVRDQVSFRFADAM
>kiamycin_1
EFRNSPAADRYLVRTRPEFIGGYLQFCERELNPAWEGLGTALRTGAPQNPAALEGNPYETLYQDRESTESFLESMDTLNTPLLRRLGEIDWSGYDSFVDVGGARGNVAHHLALNNPHLKGAVFDLPQLEGAFTTHMAALGDDGAVSFHGGDFFAGPLPESDVLIFGHVLHNWGVDERRTLLRKAHDAIRPGGAVIIYDPMVSNSAPPLYATLAALSMLVWSAGGGEYPVSDCHAWL
>kutznerides_1
DRFGLTEFGELLRSDVPDSARDDIVLSVTPGLWRAWGDLKRVIQTGAPGRATDDGLTAREVIMRDPVLGASWRAGKASSAKEFADGVGKVYDFSGFGTIAAYCGDEGTLIAAILSSAPGPRAVVYDRPEAFERTLATLTAAGVADRCELQPGDVAESVPAGADAYLLSHIIRDHTDDKAVAILRNCRAAMAANSRLLLVETVMPAVIAAEHSATYGLTDLNNLVYTGGTERDEAEYRALL
>aclacinomycin_2_1
AGARVLDVGCGRGACVFPAAERVGPEGRVVGIDVAEAMIEEATKEAALRDAAMVELRVMDGEHPDFAPHSFDVVLGSYSVIFLPDAPTALARYAPLLSPGGRL
>gephyronic_acid_1
FVSAAERMNTEMIELAGLAPGQRVLDVGCGFGGTLASINRRLRGMSLVGVNVDERQLERAAEHVKPTNDNEISWVRADACDLPFDDGSFDVIMVV
>gephyronic_acid_2
RYFDIFLDAFARGDKESAEAFGSTVHWGYWDAPDRADGTTADFVSAAERMNTEMIELAGLAPGQRVLDVGCGFGGTLASINRRLRGMSLV
>skyllamycin_1
LAWHSWRNLADAVRTDNRDASGDLQLNQITEHNYESLVRGINFWAPPIVAALADGFETFEWPTDRPASVLDIGCGTGLYSQLLLERFPKWRATGLEAPHIAPIAEAQAQRLGVADRFDVQVRDFWTESWGSDHDLLIFVNIFHLQTPESSLELLRKSKESLADGGLICIADHMVTDEQEAKPVQDRFAMLFAASMLATGGGDAFLLDEYDTWL
>lactomycin_z_1
IFRSTPVTKALTQDNPHGVFPLIRYNHMELTSRPFEHTLHSLRTGESAFKEAFGTAFNDHLEQNPEADRFCDEFQTYWAKQFAEEELDEWDLGRFSSIADLGGGDGYFLAQALRRYPQMRAYLFDLPWMAKKGEQIFANHGVGDRAEIIGGDLLTDPLPRGAECYFVKAVFMRFSDDEAVAALRNIRESIGDDTKARLLIVDSVLKPGNEWDHGKLLDVDMLVLHGGRKRTLEDWNELFS
>lactomycin_z_2
DGRYANARAAERYLDRAKDSYVGGFFTFMSYSLYPAWGRLTGLLRSGGRQEGLDDFGEWYKDLDQVRGFMHAMDSVSAPVTEELVRRFDWSAYRTFADLGGARGNLAGHLVKAHTHLRGTTFDVPAVKPLFEEHVAKLGVADKVDFQGGDFRIDPLPETDVLIFGHVLHDWDADTRELLVKRAYDALRPGGALLIYEELLDDDRRGPARSLLMSLNMRLVRSDGSEYTAAESRGWL
>safracin_1
YRNADVVEDLMATDDWQRFKDTVAFENYIVYEGQLDFTESLQKNTNVGLQRFPGEGRDLYHRLHQNPKLENVFYRYMRSWSELANQDLVKHLDLSRVKKLLDAGGGDAVNAIALAKHNEQLNVTVLDIDNSIPVTQGKINDSGLSHRVKAQALDILHQSFPEGYDCILFAHQLVIWTLEENTHMLRKAYDALPEGGRVVIFNSMSNDEGDGPVMA
>safracin_2
EGFSLTDLGASLTHDAFASAQPSALLINGEMGQAWRGMAQTIRTGESSFKMYYGISLFEYFEQHPERRAIFDRSQDMGLDLEIPEILENINLNDGENIVDVGGGSGHLLMHMLDKWPESTGILFDLPVAAKIAQQHLHKSGKAGCFEIVAGDFFKSLPDSGSVYLLSHVLHDWGDEDCKAILATCRRSMPDNALLVVVDLVIDQSESAQPNPTGAMMDLYMLSLFGIAGGKERNEDEFRTLI
>maduropeptin_1
QAEVINRALPDFAEAMRRNTNVGLRHITGPGTTLYERLTAHPDLQRIFYANMGDASRYAFAQLLDLYDFSGVRHVLDLGGGDGTNSLHLARRRPGLEATVFDQESVVRLAADRIEDPDLRKRVHFHAGDLFADPFPDGCDAILYFHIFEIWSLERNTELLRKCHAALPEGGVCVVYNFTSDDAGTGPMSA
>maduropeptin_2
VRDLAARTAEVGDAAGMMVPVEQAALLTLLTRLVSAAVVVDVGTFTGLSALAFARGLAPGGTVVTCDVTDEWLGVAREHWRRAGVADRIEFRLGAAARTLTDLAAGPAADLVFLDADKMNYPRYLGLAVPLLRPGGLLVADNVLLDGSVLDPARAPAGLPRRAAERMREFNAALAADDRLEAVMLPIADGMTVARKR
>glycopeptidolipid_2_1
DTRSAYLDLLRQDLTRYGVDELVPVGWNWLHRPFFKFGDYVLVRKRAFDAHKRDLGLDWPADALTMIGMQRLTSLQQCVETVLADDVPGDLVECGVWRGGASILMRAVLAAYGDTTRSVWLCDSFEGVPPPDTANYKADKGDRLHLAAPILAVTEKNVRANFERYGLLDQQVRFVPGWFKDTLHDAPIEQIAVLRLDGDLYESTIQALDGLYARLSPGGFCIIDDYHALDSCKQAVTDYRAKHGITAEIMEIDGTGVFWRKE
>glycopeptidolipid_2_2
ANKVKGDFVECGVSYGFLSSAIMEYLDWDRLGKTFYLLDTFAGLDPRFVSAGERNAGALEKSDKLVKNGMYVSSVDSVKANFAQWKNQRVIVGAVPETLAEVDTDAVAFLHIDMNCAPPEVETLRYFWPRLSPGAFVLLDDYANRGRDEQRIAMDDVARELGV
>quinolobactin_1
CYGLNDLSRRYLLSQSQQYVGGLAHVYSADLMWETFRDFKSAVIAGKSTLAQNIEADDHPYWQEFAAGIESTSRTTARRLVKLLDDWTARQTPLRILDVACGNGIYGFTFAQQYPQAQVTGLDWPSVASVTEGFARQFGVAERARVIGGDIFSVQIPGQYELVIMSQILHHFDPERCRQLIARARGVLAPGGKLLISDFMT
>quinolobactin_2
GLLQMLPEVQHAERVLDLGGGPGLVAQALAQRYPGLHATVFDWPPTAAVAGQLAAEAGLQERVAIIGGDLAKDGFGEGYDVIWCSSVLHFVPDCLGLLRRVHGALRPGGVFVCA
>tomaymycin_1
DLPDIGVSRSQGKLLHLLALVQRAERILEIGTFGGYSTIWLARALPPGGRLVTIEWERSFAETAAGHLARAGVADRVDQRVGRALDILPDLAKTGEQPFDLVFIDANKPDTPEYFDWALELSRPGGVIVVDNVVLGGAVADSDDPDGGVRGMRRFHEKVAAEPRVSATTIQTVGAKGYDGFTL
>tomaymycin_2
QGKLLHLLALVQRAERILEIGTFGGYSTIWLARALPPGGRLVTIEWERSFAETAAGHLARAGVADRVDQRVGRALDILPDLAKTGEQPFDLVFIDANKPDTPEYFDWALELSRPGGVIV
>cinerubin_1
PGERVLDVGCGRGACAFPAAARVGPKGRVVGIDVAEAMIEEATREAAARGAGAVEFRVMDGEHPDFAHGSFDVVLGSYSVIFLPDAPAALARYAPLLSPGGRI
>albicidin_1
IDRNMAMYLDRSSPGYLGGSIKFLLSPYIMSAFTDLTAVVRTGKINLAQDGVVAPDHPQWVEFARAMAPMMALPSALIANMVSLPADRPIRVLDVAAGHGLFGIAFAQRFRQAEVSFLDWDNVLDVARENAQAAKVAERARFLPGNAFDLDYGSGYDVILLTNFLHHFDEVDGERILAKTRDALNDDGMVITFEFIADEERSSPPLAATFSMMMLGTTPAGESYTYSDLERMF
>hitachimycin_1
QTEMLAEAYISIPREVGDLVYLMARSRGAKRIVEFGTSFGISTLFLAAAARDNGGEVITTEWHAGKAEIASKNIADAGFDDIVDVRVGDALETLKDLPGPIDMVFLDGWKDIYL
>GE2270_1
EFGLNPAAELLRDGRPDRLRDWLDLTGPIGRADLAFGSLLDVVRTGKPGYPMIHGRGFWDDLAAEPALATAYDTLMGGKRQWAATTLAALDWSRSRHVVDVGGGNGTLLSCLLAAHPHLRGTVVDRPTSAKAAGAVLASAGVADRGEFRAGDFFEPLPVHGADTYLLSSILHDWDDAAATAILRRCAEAAAPGGRVLLCELVAMAGPDRRTVTHMDLCMLVYFGGRERTAADFAALA
>JBIR_34_1
GRYSNAPLAERLLAPRGPESWRNIFLSRHRTDYAGMAHMTQALRSGTNDGLKVHVGVGGSVYERLGADPETEAILHQSIAAFAHQEMHGLLHTADLEGTGHLLDVGGGSGAKAAAIAGHFPGIMVTVFDLPSVTQLAARELPPGVDGRVRFQPGDMFVDPFPAGVDAILFSSVLDVFDAQRVETLLAKAYDALGPGGRVLIYSCNTAPDEAGGVIATSLSLFLNVIATGEGMAYPVADYERML
>tiancimycin_1
VADVFRTGEGVARSAYADGLFTAMERMSATWLDGLLTDHWIPAVDGLLPALEKGGAVADIGCGGGRALLRMARAFENCRFTGYDLHGPNVRRAREAVAAAGLDGRVTVEEADAGGALAALAKKDGGPGGPLVLVTLFDVLHDVAAPEELLRTVREALAPHGTLLVLESLSADDPADNTGPQSTVLYATSTLY
>tiancimycin_2
AVFGPTGLSRLLQSDHPRSMRPWLDLEGPVARGDRTCVHILEALRTGGPVHERTYGRPVWEDLAARPALGAAFDAAMAQRASWIAGDVAAGFDWSAVRHVMDVGGGTGGVLAEVLRARPGLKGTLLDRAPTVAAGREAWGASEAGQRCTFSGGSFFDTLPSGADACLLVNVLHDWADEHALAVLRRCAEAVGPRGRVLIAEHLVEEGAGGPGAAGLAELDLVMMLVYGGRERRLDELADLA
>tiancimycin_3
RLESGAPVAHVGSGGGRALVLLAQAFPNCRCTGYDRLRLNVERARQEAADAGVTDRVEIVEGDAERLLPATGDHALVMCFDVLHDAPDPAAALRAVRGALAPDGVFLLLESNGADRPADNSGSAAAMLYGAS
>sibiromycin_1
VQYQDKIAYQPAADYVESLRTGQNAGIRHFPGTTRDLYSRLAAVPGLEELFYRGMHAWSQLSNPVLLAQPDFTRVHRVLDVGGGDAVNAVALARAHPSLRVTVLDRPGALEVARKTIAEAGLEERVRTHAADIFTDSYPAGHDCVLFAHQLVIWSPEQNLTLLRKAYDAVEPGGRVLVFNAFTDDDRTGPLY
>istamycin_1
RTTFEYVWGSHIPGAVAEFGCFEGFSSLMLADLMLEFDAQSDWYTEIFPRHLYVYDSFQGFPKSTNPVDSISYEVADSGYWRESEDASPPGTEEMLRAEFTRRFGETGWSVVPGMFEKSLETSPITHEVAVANLDCDLYSSSVEVLDHLLGRRLMPDGAVLLMDDYNCNRA
>istamycin_2
LPSLVVRMWADADVREGHTVLEIGTGTGYSTALACERLGSADVTSIEVDPHRLAQAADALYGLGYTPTLAVADGLYGYWPEANFDRIVAACSFRAVPPALLAQTRPGGKILL
>cladoniamide_1
LVGQLPKGQRALDIGCGGGNNCVMLAERYDEVVGVDISRRMLDIAAAKPARVPVRYQHRSALDLTPAADGTFDLVMSVNAVFHLGPAPRVLPRLRDLVAPGGRLVV
>cladoniamide_2
DRRAFHRTPLLDTLRAGTPHSLRTIALVHGSPGHWLPWGLLPDAVRSGTPQTGAALGRDIWAHFLAHPEEGERFATSMTELTAGLAEEVAALIDTDGVGVAVDVGGANGALVHALLRGDPRPRGVVVDLPAVEESARAEAREAGLADRVTVVGGSFFDPLPRGDLFLLKAVLHNWDDDACTAILRNCRAALNPGGRVIVVEMPLGPLGEPGFAPLLDLNMLAVLPGRERDLPHYDALF
>chelocardin_1
GPSLKLGASDWEWDAQKRLTEAVRKGGAVMDSHALTPEFDYWEDFAENTTWFNNGAAELMAEQLLPWAKDRDSVDVLDVACSHGYYGVNLAKAEPKARVWGVDWPNVLPITAKNYERNGISDRFEGIPGDMFSVPLGGPYDVVMITNVLHHFSADTSTNLLRRLFDVLKPGGRIAVTGHTFVEGERPEDKPLPYLFSQIMLVMTDEGETHSTKTYERMF
>chelocardin_2
DKFVHTDASRLLREDAPRSLKHILLWGTEPWTWELWPHLDQAVRTGKNVFDDLHGKDFFEYLHEQWPESAEVFDKAMTQSSKLSALAIADRLDLTGAERLADIAGGQGNVLATLLSRNEKLNGVLFDLPAVVAGADERLRVGGALADRAELVAGDCRREIPVQADVYLFKNILEWDDESTVLALRNAVAAGRPGARVVIIENLVDGTPEMKFATAMDLLLLLNVGGKKHTKD
>herboxidiene_1
GTYALTELAGELLSGHPANLRQWLDADEVAGRLDTTFPYLVDAVRSGTPVHEKVHGAPFWADLGASPARTESFDRLMAQVSQSTRGIGTVYDWAGVRHVVDVGGGTGALLREILQAHPHLRGTVADQAGSVAEARRYLAAHGLGDRADAAVHDMFDHLPAADACLLSRVLADWDDESAERILRTCAAAVPEGGRVLIAERVLPGEPAPGTPDTAEDLAETRRLTSHDLRMLVLLGGRKRSVADYARLA
>lipomycin_1
GVYRNSALSDQLRDDHPQSMRHYVMLSGGLYADTFTAVTHTLRTGESAFRHLHGTRIYEYLEQRPAEADLYDKAMADLARPVAAALAGTYDFGAVRSVLDVGGNSGELLKGLLTAHPHLTGTCLDRPDVCARATAELAASDREDLKDRLVYRPGDFLQEVPAGSDLYTVKNVLHNWNHEHSVVILGRIREAMERTDADRSAGRRARLLVIEPLIETDLDWMRVL
>thailandamide_1
LMQARQIEMRQVLFGREHFERISRVLDIGCGMGTDVIQLAKRFAHLRTTGYTITRAQAELGAGRIAREGLQGRAEIRHGDSAKDPFPGKYDLVIGIEVICHIQDKHGVFGNIARSLDDDGHVLLMDFVAN
>coumermycin_1
SDSSLYLDLMIKVLAGTVYEDPAHRENFSHRDSTYREEVRSEGRDWPANAHTMIGIKRLENIRQCVEDVIGNNVPGDLVETGVWRGGACIFMRGILRAHDVRDRTVWVADSFQGIPDVGEDGHAGDRKMALHRRNAVLAVSEDEVRRNFRNYDLLDEQVRFLPGWFKDTLPTAPIDALAVLRMDGDLYESTWDTLTNLYPKVSVGGYVIVDDYLMCPPCKDAVDEYRARFGIADELIRIDRDGVYWQRT
>SF2575_1
GNHFELTDMGKELCEQGPGDPRSWLDINTASSRADLALVGLLDAVKIGRPVNTQDWSDLDADAELSDSFDEQMASGAAAKAPALIEGYDWSTVKHVVDVGGGNGTLLAALLKGRPHLKGTVVDRPHPIEGAKRKLAAEGVADRASTSAQSFFDPLPKGGDVYLLSGVLHDWNDADASRILARCAEAAGTEGRVLVMESLVEHGNIEASTTGMDLMLLVVTGGRAHSAEDLTELA
>SF2575_2
RDGRQYANSTVSQEVLVPGGPVFLGGRVKATAQRHYHTWGKLTEALRDGEPKAAMGLGAMERLYSDPALARAFFAHMDANNAVVALQLATVVDWSSYKSFVDAGGARGNVAATLVKAHPHLRGSVMDLGKAEPLFDELMAERGTTGSVVFHPGDFFTDDLPAADVIVYGHVLHDWSAEQCQVLVERAYQALPSGGALVVYDQMLDEESPDLRSLVGSLNVALLSEGGSEYTVAEFRAWA
>oxazolomycin_1
QMSLRDDDVLRDLRAETAGMPMLRAMLVLPEEAQLLALLVRVTGARNVLEVGTFTGYSSLCMARALPPGGRVVTCDISERWTAVARRYWERAGVDGLIDLRLGDAAETLDTLCAQDGPGGFDLAFVDADKANYLRYYEQSLALVRPGGLLVLDNTLFFGKVVDPAAQDPDTLAIRELNTLLRDDERVDLSMLAVADGLTLVHK
>oxazolomycin_2
LLALLVRVTGARNVLEVGTFTGYSSLCMARALPPGGRVVTCDISERWTAVARRYWERAGVDGLIDLRLGD
>azicemicin_1
GHYALTPVGALLRKDVPDSLHAVVRVSTDETILRGWRDLDWSVRTGQTAFDRIHGTDFFAHIAENAELSALFNASMGAGTTEVAEAVTKHYDFSRFGTVVDVGGGNGTLLAPILAAEPELRGIVFDSEEGVEQAAGVLADAGVADRCEIVAGDFFRAVPRADLYLLKNILHDWDDTRSAAILANCRAAIPEHGRLLLVESVLPATPEPGGPPDDYLMDINMLVNFGGRERTEGEFHALLT
>polyketomycin_1
PLVDIQADIINRSLGDFAESMRQNTNVGLRHIEGPGDTLYERLTAHPELQEVFYRNMGDASKKAFAQILDRYDFSGLHHVIDIGGGDGTNSIELARRYPHLEVTVFDQESVTRIAAQRTEDAELSKRVHFHPGDLFTDALPEGADGIMFFHIFEIWSLERNTELLRKCYEALPPGGVCLVYNFVSNDEGTGSMSGGLVSPYFLTLASGEGMTYAPKDMD
>polyketomycin_2
QGDRYAHTPVSRLLRGDTPRSLRDMVLWATEPWTWEVWPRLADAVRTGKGGFGETHGKDFFTYLYEDAPESAEVFNRAMTQASRLSSGAIAETLDLRGDLTVVDVAGGHGDLIATVLERDPSLRGALFDLPGVLEDVDARLRKGGALEGRCRLVAGDCRESVQVEADVFILKNVLEWDDAATVAALRNVAASARPGGRVVVIENLVDGSPETGFTTAMDLLLLLNVDGRKH
>polyketomycin_3
DGRQFALTPLAEGLRTDLPDGVRDAVLLDGSGFFWGSFGSILHSARTGRPGFDAAHGMSFWEYLQGNPEAGEVFDDAMTTISRRLGGLYLDRVDFSRFPVVADVGGGRGYFLAEILRRNPGVRGVLFDRAQVADTAGELLSEREVAHRVEVVGGDFFTDPVPAGCDAYVLKTVLHDWPDEKAVEILRGVRRAIGDSAARLLVLEQVVAPGNTWDTAKFLDVDMLVVMGGRERNLDEWRALL
>rubromycin_1
GAYEPTDLGALLRDDLPQSGRDWLRLDGPTGRGEAAVFRLLDAVRSGEPVYSALYGQEFWTDVESDGALAEAFARRMAASMRWVVPELLAQGHWQSVRHVVDVGGGSGDLLAAVVDATPGARGTLLDLEAPAAAAER
>allylmalonyl_coa_1
KVSLRDDRVLGGLRAESAGLPGGNALPVSAEEGQFLEFLVRLTGARQVLEIGTYTGYSTLCLARGLPPGARVVTCDNTAKWPEVGRPYWERAGVAERIDVRIGDALDVLAGLRDEPGAGPGSFDVVFIDADKERYPAYYEAALPLVRGGGLIVVDNTLFFGRVADDAVTDPETTAIRALNAGLRDDDRVDLAMLASADGITLLRKR
>allylmalonyl_coa_2
QFLEFLVRLTGARQVLEIGTYTGYSTLCLARGLPPGARVVTCDNTAKWPEVGRPYWERAGVAERIDVRIGD
>erythromycin_2_1
RSRYPHADSVLDVACGTGSHLEPLSRSFGRVEGLELSPAMIEVAERRYPQLTVTQGDMRAIDLPRQFDAVTCMFSSIGHMVDVDELDAALDSFARHLAPQGVVVV
>erdasporine_1
GRFGLTPAGEQLRADHPESLRSWVMFQGLFNGVYAESMHSLRTGEPTVPLVFGEPLFAHLQHHPEHGRIFNAAMGQHSRLTGKALAAAYDFTGARQIVDVGGGDGSFLSAVLRAHSESSGVVFDQPYLSDAAGKQLGAAGLGERCRFVGGDFLRDVPSGGDVYLLKGVLHNWPDDQAVVMLRNCRRAMGADGRLLLIEWVVPDGDVPHPSKFLDLAMLFVYGGRERTEKEYVALLT
>undecylprodigiosin_1
VRLLEVGCGSGTYVRYAAELNPRLSALAVDLQQDVADSAAANMAEWGLTDRVETRQADLRTLDAQPQFDLVTLHNNIYYFPEAERVEALRRAHDLLAPGGRLLLT
>chrysomycin_1
EGRVFALTEAGDALRGDSPHSMRNFARWVGLAADRNTWAGLADSVRTGDPAFARVHGQDVWEYMRDRADVSTVFDDAMTEASRQLIAPVVDAYDFGGTGTLVDVAGGHGALLAAILAAHPGLRGLLYDRPEVVEGAKQTFQDRGVDDRVEIVAGDFFDSVPEGKDAYLLSNVIHDWDDEPSLTILGNCRRALAEGGRVLLVEAVMPERDASSPTVTLMDLNMLVLCGGKQRTETEFAELL
>mannopeptimycin_1
TTVADLGSGSGERLIQIARRFPGVRGLGVDIADGAIAMAEKEVAAKGFGDQISFVRGDARTIDQVSARGEFAEVDLLTCFMMGHDFWPRENCVQTLRKLRAAFPN
>lobophorin_1
EAYLDLLKKCLLRFHDGAAFPYTTESGGESDQRLAYLAGKGIMPHVQADTMVSRDRLDNIQQATATVIREGVPGDFIETGVWRGGSCILMRAALTAYGDKTRKVWVADSFDGFPPPTDKYPSDPWKGQSQDIIGTMGVSLKVTFDEVKDRFDRYGLLDERVEFLTGFFANTLPDAPIEKLAILRLDGDLYQSTYEALEALYPKLSVGGYCIIDDYFYTMCSKAVDDYRREHGIDEPIEAVDWTCVQWRKT
>mithramycin_1
VLDVACGHGLYGYTVARRYPQARVRSVDWPGVLEHSRGHAERLGVLDRVELTPGDMFDVPLGGPYDLSLITNVLHHFSAERAGEMLRRLAEATRPGGRIGIVAVTADGRDPASDPVPHLFAALMLAWTHEGESHALETYRDLL
>mithramycin_2
GGTYANTPRAEHFLVPGHPHYIGGAVLQHGRVHYELWNRFADALRDGKATSGKDITAGAVVEEQPDLDRARRFLDHMDTFNQFVVAELSKALDWSRWKTFVDVGGARGNVAAQLVLDHPDLKGSVFDVPGVEPLFDEHMAARGTTGRVDFVGGDFFTDALPAADVVLFGHVLHDHPEESRKRLLGQAFRALPPGGTLLVYDAMLDDRSEAGAYLQSLVCSVILDGGSEYRVRDITAWA
>APE_vf_1
NYVLANLGHFLLHDGMTNANLDFTADVCYAAMMHLTEAIQEGTPAGLKELGDWPTIYEGLSRLPEKAKESWFKFDHFYSDRSFPILLEKVLSQKPKRLFDIGGNTGKWALQCCNYDNDVEVTIIDLPQQIEMALKNAKEQGFADRINGHPTNMLDKTLPLPQGADVWWMSQFLDCFSPMEILSILKRVRAAMSTDAKVYILELFWDAQKYDAASFSLNATSLYFTCLANGNSR
>actinomycin_1
TGEDLYHRLSADPELEQLFYRCMRSWSRLSNPVLVEKADLTGVRRVLDVGGGDGVNAIALAQANPGVEFTVLDLPGTVEIARKKIAEHGLSDRISVRAADIFADTYPTGHDCVLFANQLVIWSPQENIRLLGKAHAALPDGGRVLVFNAMSDDSGDGPLYA
>actinomycin_2
TGTDLYHRLCANPELEQLFYRCMRSWSRLSNPILVEQADLTGVRRVLDVGGGDGVNAIALARANPGVEFTVLDLPGTVGIARKKIAENGLTDRITVLAADIFTDTYPSGHDCVLFANQLVIWSPEENLTLLRKAHRALPDGGRVLVFNAMSDDSGDGPLYA
>azinomycin_b_1
GRYRNTAVAAHYLVPGLPDYFGGYVQMVARYTAPGWLRATEAVRTDAPTKPVPDPDRNMFEEGNRPESFWEGLFTFSTLTARQLAASVDLSGVRRIMDVGGGAGATLIELCRQHPHLSGTVVDLPHVCALAGERIAAAGMTGRIDTAAADFFADPLPSGHDAVLLSMILHDWDESQNRKILASCLDALPSGGTVLISELLVDDDKSGPVDAALMSMNMLVGTWGRNYTGAEYTDWL
>chromomycin_1
GELYLELMKRVLANVVYEDAPVGWYGDLDGYDTKARSQGLDLPTTAHTMVGLKRLANVQACVERVIRDKVPGDLIETGVWRGGVCILMRAVLEAYGVRDRRVWVADSFEGVPVVHSASHPLDRDMALHRINGVLKISQEEVRENFSRYGLLDGQVDFLAGWFNETLPGAPVDSLAVMRLDGDLYESTMDALTHLYPKLSVGGFVIIDDYNIEPCRQAVWDYRSRYGIEEPIEPVDTCGVHWRRT
>chromomycin_2
RFSLAPGADSTLVTTHPDYYGDAVRLAASDYEWDAIKRLGDAVRSGGSVMEVNAETPAYTFWEDFAALGTLNTPPIAELVARHVLPGTKERDEVKVLDIACGHGLYGYTLAAHDPRARIWSLDWPNVLAVTENNAERLGVRDRAHFIPGDMFEVPLGGPYDVVVVANVLHHFSTERAKRLLARTADAVRPGGQLVAIAISTGDGPPHLDPVPHLFSALMLAWTSQGQVHPLSDYEEM
>chromomycin_3
GHYSNKPEAAAFLVPDAPGYLGGSIAQHARRHYRSWASLTDLLRNEPAADSPPATAGGDPAKVQLDFHKDFENLDNVRRLMGHMDAFNTFVAHELGRCVDWSRHRTFLDVGGARGNVAARLVRTHGHLRGGVFDLPAVRPLFDEHMAALGTASQVGFTAGDFFDDPLPESDVVILGHVLHDWPPAARERLLERVFAAVRPGGRVVVYDAMLTDERDDAVALLQSLNCSIMRDGGSEYTVAECRGY
>marineosin_1
VEAAVDRNLERSRPVRLLEVGCGSGTYVRHAARLTPRLSALAIDMQKNVADQAASNMAEWGLTDRVETRQGDLRTLDLEPQFDLVTMHNNIYYFPQDDRVETLRRARRLLAPGGKLLLT
>lymphostin_1
TVADLLELKPGERVLDLGCGRGACLFPIAAQVGTEGFVLGIDQAPGMVEACGADLEARGLADRAQVRLGDVQSFTVDRPFDAISAGMVLFLLPAPQQALAAAAAALRSGGRLVA
>BE_54017_1
EGRFASTPLLETLREGVPGSFRDIAIVHGSPGHWLSWGRFPDAVRTGEPQTKAALGSDIWTYFQSQPQEWERFSNSMTELTDGLSREIGALLDTTGLTTAVDVGGANGALLHPLLKANPGLRGVVFDLPTVEATAVAEAEKAGLAGRCTFTGGSFFDSVPEGDLFLLKAVLHNWADESCVQILTNCRKALRPGGRVVVVEMPLGPLGEPGFAPLLDLGMLAVNAGRERDLDQYDALF
>glycopeptidolipid_1_1
DTRSAYLGLLRQDLTRYGVDELVPVGWNWLHRPFFKFGDYVLVRKRPFDAHKRDLGLDWPADALTMIGMQRLTSLQQCVETVLADDVPGDLVECGVWRGGASILMRGVLAAYGDTTRNVWLCDSFEGVPPPDTAHYKADKGDRLHLAAPILAVTEKNVRANFQRYGLLDDQVRFVPGWFKDTLHDAPIQQIAVLRLDGDLYESTIQALDGLYERLSPGGFCIIDDYHALDSCKQAVTDYRTKHGITAEIKEIDGTGVFWRKE
>glycopeptidolipid_1_2
SKVKGDFVECGVSYGFLSSAIMEYLDWDRLGKTFYLLDTFAGLDPRFVSAGERDSGALEKSEELVRNGMYVSSVDSVKANFAQWKNQRVIAGAVPETLEEVHADAVAFLHIDMNCAPPEVATLRYFWPRLSPGAFVLLDDYANRGRDEQRIAMDEV
>uncialamycin_1
LERGGEVADIGCGGGRALVRMARAFGNCRFTGYDLHRPNVLRAREAVRAAKVDDRVSVEETDAVGALAAGTRASGDSLPLLLVTMFDVLHDVAAPEELLRTVRESLSPDGALLVLESLSADDPADNTGPRSTVLYATSTL
>glycopeptidolipid_3_1
DSRSAYLDLLRRDLTRYGSDELVPVGWDWFHRPLFKIGNLMLVRRRPFDPRKRDLGLDWPADALTMIGMTRLTSLQQCVETVITEDVPGDLVECGVWRGGASILMRAVLSAYGDESRRVWLCDSFAGVPAPDAAKYKADKGDRLHLAAPILAVSEQDVRANFQRYGLLDDQVRFVPGWFKDTLHDAPIERISILRLDGDLYESTIQALDGLYERLSPGGFCIVDDYHAIDGCRQAVTDYRAKHGISAEIVEIDGTGVLWRKE
>glycopeptidolipid_3_2
SKIDGAFVECGVSYGFLSSAIMEYLDWDKLGKTFYLLDTFAGLDPRYVTEAERASGALERSEEHLRNGFYVDSVDSVRANFAQWKNQRIIVGAVPETLAEVDAEAVAFLHIDMNCAPPEVATLRYFWPRLSPGAFVLLDDYANRGRDEQRVAMDEVASELGV
>calicheamicin_1
APVTDWLLRAAGLRPGHRVLDVGCGTGEPSVSAGRLVAPTGRVLGIDLSPEMVDRARR
>calicheamicin_2
ARLLDVGCGTGAHLETFATRFPHVEGLELAPAMLALARHRLPGVRLHAGDMRT
>calicheamicin_3
LYRQVLDVPGVIMEFGVRFGRHLGTFAALRGVYEPYNPLRRIVGFDTFTGFPDVNDVDRVGPTAYQGRFAVPGGYPAYLKEVLDAHECSDFFGHVTQRSVLVEGDVRETVPRYLAENPQTVIALAYFDLDLYEPTKAVLEAIRPYLTKGSIVAFDEL
>calicheamicin_4
GRFALTDKGAALRSDSPVPARAGILMFTDTMFWTMSHRVASALGPERPAFADIFGSSLDAYFDGDAEVEALYYEGMETVSAAEHLILARAGDFPATGTVADVGGGRGGFLLTVLREHPGLQGVLLDRAEVVARHRLDAPDVAGRWKVVEGDFLREVPHADVHVLKRILHNWGDEDSVRILTNCRRVMPAHGRVLVIDAVVPEGNDAHQSKEMDFMMLAARTGQERTAAELEPLF
>calicheamicin_5
TFALTEQGEVLRADVTGSMRELVLLLSGPESWAAWGQLEHSVRTGEVAWEHVHGRSCFDHLMADPQRQAAFNAAMAEGSRAFVPTLLSAYDFGDLRTVVDVGGGSGALLAGVLAAHPHLRGTVFDTPDGVADAARTVAEQGVADRCGVETGDFFVSVPPGADAYVLKSVLHDWDDEQCVEVLRTVRRAVRPDSRVILVESLMPTTVTTAPSVAQVVMNDLNMMVCHGGRERTVAEFRELL
>GE2270_2_1
GRFALSPAAELLRGDRPERLRDWLDLTGPIGRADLAFGSLLDVVLTGRPGYPMIHGRGFWDDLAGRPELAAAYDALMGGKRDWAATTLAALDWSRSRHVVDVGGGNGTLLSCVLAAHRHLRGTVVDRPSSAEAAGAVLASAGVADRCEFRAGDFFEPLPVKGADTYLLSSIVHDWDDSSAVAILRRCAEAAGPGGRILLCELMAGGGRDQRAVTQMDLCMLVYFGGRERTGDEFAALA
>rebeccamycin_2_1
LTDEMIALLDVRSGDRVLDVGCGIGKPAVRLATARDVRVTGISISRPQVNQANARATAAGLANRVTFSYADAMDLPFEDASFDAVWALESLHHMP
>rebeccamycin_3_1
LTDEMIALLDVRSGDRVLDVGCGIGKPAVRLATARDVRVTGISISRPQVNQANARATAAGLANRVTFSYADAMDLPFEDASFDAVWALESLHHMP
>griseorhondin_1
GDRYGNSPLAEAYLVPGTATYLGGFVELTNETLYGTWGRLTEALTTGAPQHLDPDKGGFVGDRHKDPEKMKRFFAGLDAYSDRMGVEIARAVDWSRHTSFTDLGGARGNLAAVLVKEHPHLTAGVFDLERTRPLFTEHTTRLGLDGRVAFTGGDFFTDDIPKADVIVLGHILHGFGTDRRRELLNRVFAAVNPGGRVLVYDRMIDDERRDPERLLSSLHMRLVSQDGSEYRVGDLRTWL
>collismycin_1
GRFALTEAGALLRRDDPASLLAFAAFLTHDVFQRNWLNLQESLDTGLPAFDTAFGLPVYDYLSGRPELAALFHAAMSRRHRPLEMAAAISAVYDLGRFSTVVDVGGGDGTLLAAFLDRYPHLTGTVLETEAGAARARETIAGSGLTDRCRAVAGDFFAEVPKGADLYLIKNVVLNWDDERAWTILRRVRDAMPDHGKLLIAEPVLPDTADADSLNHAALENPYLTDLHMLVTIGGRQRTRAEYTAI
>collismycin_2
GSFVHTEKSRALREDSPDSIKYLVLWCTEPWLWSLWGDLDESVRTGGEIFTRTHGRRFYEHLHTRWPESARIFNRAMTQQTRLSATVIADMLPMSGAGTVADVGGGQGLVLGTLLERHPHVRGFLLDLPEVVANVDARLHPGGELADRVRLVPGDCLEGISVEADVYLFKNILGADDDTSVRILRNAMKAARPGARMVIVENFVDDGPGERLASALDLRMLLVIGGQKHTRA
>cyclomarin_1
LRVSDLGAGAGGLLIKLLQEDPARTGTAVDSNGAACAAARQAALAGGVHDRLTVVERPIESLVDDPEPVAGADAILASYVMHDIVADDRIALGVLGALRDALAPGGFLAVADAVSYARRPEERTF
>herbimycin_1
ELSLRDDEILAGLRAETAGLPAAQAMQVMPEEGQLLGLLVRLVGARSVLEIGTFTGYSTLCMARALPTDGTLVTCDITAKWPGLGRPFWERAEVADRIDVRIGDAKETLAGLRREGREFDLVFIDADKTGYAHYYEESLAMLRRGGLIVLDNTLFFGRVTDPAAQDADTAALREVNKLLREDGRVEISMLTVGDGITLAVK
>herbimycin_2
LVRLVGARSVLEIGTFTGYSTLCMARALPTDGTLVTCDITAK
>prodigiosin_1
RLLEIGCGSGVHVRHAASLNPHLTALAVDLQAEVAKQCAENIEDWGLADRVEVTQGDLRTLDLEPQFDLVTMHNNIYYFAEDERVEALRRARELLTPGGRLLVT
>calyculin_1
ELMKSKQVEMRQVLFCSEDFQRIESLIDIGCGHGTDVIQVAGLYPHITTHGFTITKAQAELGNHRIASRNLAPRARIFHKNSAVAPFPGRYDVAIGIEVTFHIRDKDALFGNIVAGLKDNGRILLMDYIA
>glivocarcin_1
TLELTELGRALASDDGSMRNFARWTGSTAERATWAHLATAVRTGRSPFAAMHGSGVWEFMESDPDTAAVFNSAMTELSKRVIQPVIEAFDFSRFSSVTDVGGGRGALLAAVLRKHPEMTGVLFDQPDVVSRSLPELSDAAVAHRVTVKSGSFFDGVPSGSDLFMISNVLHDWDDGRSRLILRNIAEAMHEGAHIAVVEAVAGLDDTADKAISLMDMDMLLLCEGKQRTVEEFRLLM
>benastatin_1
ERTFAHTDMSLPLREDSLDGIRNLILWIGAPWTWQAWPRLEEALRTGKSVIPSLYGKEFYDYLREDAPDDEQLFARAMTDSSARSSDVVAQTIDLTGVGTVVDIGGGQGLLLRTLLDRFPKLNGVLFDFEQVLAGAHEDLKDGGRLASRTRIVPGNCLESVPVEADVYILKNLVEWPDENSRAVLRNITASAPPGARVIIIDSLVDAHPDEMRITTTLDLFLMMNVGGQKHSLADFDP
>arimetamycin_1
RLPGATSVLDVACGTGAHLETLAALFPDVAGLEYAPAMRAVAKQRLPGITVHAGDMRD
>caprazamycin_1
NAADAYLDLLKRCLTRYDGHQIFLGPPLAKPRTMEQIERGRFAHQDADTMVGWPRLDNVRHCVETVLREQVPGDLLEAGVWRGGCCVYMRGILKARAVDDRTVWVADSFAGFPEPDIDRYPDDSVYDSPVAREILDGFGYPIAISLDEVKSRFRSYGLLDSQVRFLAGYFADTLPQAPVERLAVLRLDGDMYQSTLESLEHLYPKLSAGGYCIIDDYSLEGCRKAVEHFREAHGIGEPIEKIDWTGVFWRRT
>aclacinomycin_1
AGARVLDVGCGRGACVFPAAERVGPEGRVVGIDVAEAMIEEATKEAALRDAAMVELRVMDGEHPDFAPHSFDVVLGSYSVIFLPDAPTALARYAPLLSPGGRL
>elloramycin_1
KAFSATPLSDGLRPGHPGSVLPLVQYNNLDLTRRPFEQILHSVRTGAPAFDEVFGRPFYAYLESHPEAGEFFERFMLHWSRRLVAEELPKLGLERFRRIVDLGGGDGGFLAEVLRRQPGTTGVLMDLPRVAASARARLAEAGLADRVTVVPDDFFRAPIPTDGDAYLLKGVLHNWSDDKVRELLHRLRAAIGPREATLLVFDVVMSPDNRWDHGKFLDADMLVLFGGRERTLPEWRKLF
>elloramycin_2
EDARDLYLDLMKKVLTNLIYRDAPIQTFVYDGEPDADPRLLGRDWPSVAHTMVGLKRLDNLQYCVETVLADGVPGDLVETGVWRGGSSIFMRAVLRAHGDTARRVWVADSFEGMPEVGADSHAVDREMRLHEHNGVLAVPLEQVRANFERYGLLDDQVRFLPGWFKDTLPGAPTGRLAVIRLDGDLYESTTDALENLMPRLSPGGFVIIDDYAIDACRDAVHDYRGRYGISDPISEIDGTGVFWRH
>rhodomycin_1
QGRPLRPTRLGMLLADGHPAQQRAWLDLNGAVSHADLAFTGLLDVVRTGRPAYAGRYGRPFWEDLSADVALADSFDALMSCDEDLAYEAPADAYDWSAVRHVLDVGGGNGGMLAAIALRAPHLRGTLVELAGPAERARRRFADAGLADRVTVAEGDFFKPLPVTADVVLLSFVLLNWSDEDALTILRGCVRALEPGGRLLVLDRADVEGDGADRFFSTLLDLRMLTFMGGRVRTRDEVVDLA
>rhodomycin_2
AGRLLDVACGTGGHLRHFADLFAHVEGVELSEPMAEEARAALPGVTVHAGDMRD
>JBIR_100_1
RETSLRDDAILRELREATAVLPAGRAMQVMAEEGQLLALLAGLTGARSVLEIGTFTGYSTLCLARALPPGGHLVTCDIDERWPAFGADYWRRAEVEPRIDLRIGDANDTLAELLADRGPGSFDFVFIDADKANYVGYYESSLKLVRQGGLIVIDNTLFFGRVADPAAQDPDTEGVRALNRLLHHDNRVDLSLLPMADGITLARK
>cystargolide_1
ATARILDLGAGTGLLGAALRERLPDAELLLQDRSQAMLEQARQRFADDDQVAIRVADHLDELPAGPFDAVVSALSIHHLEHQDKQDLFTRIRKILRPGGIFVNVEQVLAPTSELEK
>napyradiomycin_1
MEMIKVVTLRQLFYLTDSVRTGTTVGLNKLYGHEGNLYDALAEHKDLREPWARLMNGETAHIDPWFFDNIDVPPGSNVLDLAGNTGLGAIHTCKLKASPGLRVTTFDLPEKEEECLANFRSHGVEEHCSFIGGDVFEEVPKGFDVVLIKHFLPMFDKSDVFKILEGVNRSMDVGGQVHLLVPVFPENIKDSDNYTVDFFPSFFIGCAMGQGGAQKMSTWQKWL
>cremeomycin_1
GYALTPVGELLRTGTQDSMRDHVRIYGSHFYRAWGALDHSLRTGRSAFTEVYGSDLFRYLNQHPDLSLTYERAMVAGTPFFAQVPEVHDFSGARLIVDVAGGHGALLHEILKSCPEPRAVLFDAPHVIAETADRPIASEHGDRVTLVPGDFFEGVPQGGDVYLLSRILHCFDDEACLRILAHCRSAMAPGGRLVVVERLLTRGTGSSLAQGYNMHMLVVLGGGRERDEDAYRTLL
>belactosin_1
PTAPRVLDLGAGTGLLSAAILRELPDSEVVLVDRSELMLTQARGRFASQDGVTVQTGDLTDPLPEGGFDAVVSGLAIHHLSHTGKRDLFRRIREALRPGGVFVNVEQV
>avermectin_1
EVPGVIMEFGVLHGRHLATLTALRSIYEPYNSLRRVIGFDTFTGFPDIDEADEVSTSAVPGRFAVPDGEVEHLRQVLAAHEANEPYGHTQRSFVVQGDVRETVPQYLAEHPHTVIALAYFDLDLYRPTRELLDVITPHLTRGSILAFDELT
>lysolipin_1
EGRFALTPAAEGLRSDAEDGVREMFLFACDPMMWRPYEDLLHTVRTGQPSFDRAFGMSFFDYLRADPDSARLFDQAMVQNHYPGTDRIFEEFDFSRFPRIADVGGGRGQFLAEVLSRHPDCSGAVCDQAQVIADAKAEFERRGVADRASVVETDFFTRVPAGFDAYFIKHTLHNWDDRDAVRILTRVREAIGDRGAARLLIVDMLLAGPGEWDLGKLTDVEMMAALGGRERDRQEWDRVA
>lysolipin_2
DRYRNASGADAYLVKGKQQYIGGFLERSNRNLYPAWGRLTEALRTGKPQAGGDFFTMIDNPVLLAQFADMMDALTRVLGPQLIEAYDGWGDYRSVLDLGGCRGNMAAQIVAAHPGLTGLVFDLPQLRPLFDEKMAEYGLTGKVTFHAGDFFADPLPCADIVMYGHALHDWDADQRGFLINKAFGSVNPGGVLLVYDRMLDNDPSHVENLVISLDMLLVTEGGSEYTVDEVRAH
>lysolipin_3
GVYRNGAAASACLVSGAPAYLGGFLHMADQVMYPAWERLDASLRSGEPQAATYTGSDMFGQLYGDDGKQSDFIRMAEDASRPLIPALVEAFDWAAYNSVLELGGCRGNVLAHLVGAHPHLTATVLDLPQLQDAFTAHMSALGTAGAVSFHAADFFTDPLPEAEVVMIGHCMVDWTDEQRRALIANVFPAVRPGGAFLIWDPMLVPGQDSYLRNLVRGLNFQLMTPQGTN
>FD_891_1
RMTEQLYERLDVSAGHKVLDVGCGVGKPAAWLARKTGATVKGANVSRNQLEVARDRVRSEGLEDRVSFDLADAMHLPYADDSFDRIWAIESMIHMPDRDQVMREMARVLRPGGRLAI
>aldgamycin_1
IVDIGGGTGHYHAKVVDAFPDVDGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLQDA
>aldgamycin_2
DADLYLDLLKKVVTNMIYEDQTNVAGLITSSSYSAELRAVGEDFPHVAHTMVGLKRLDNLQKCLEDVLRDGVPGDFAETGVWRGGACIFARGLFQAHGVRDRKVWVADSFQGFPKTTEDDHQLDVDIDLGQYNEVLSIPVDVETVKRNFARYGLLDDQVRFLPGWFKDTMPTAPIEKLAVLRLDGDSYAATREVLTSLYHKVSVGGYVIVDDYCIPACRQAVHEFRDEHGITDEIHQIDRQGSYWRRS
>aldgamycin_3
LDKDLADSMRPDTPGSAVDHGTFDAGHRAEGLDVPTVAHTMIGLHRLDNIQKCVEQVLRDGVPGDFIETGVWRGGACILMRALLKAHGVEDRNVWLADSFAGVPVTSEDSHPLDQAMEFHNLNWVLSCSEEQVRQNVARYGLLDDQVKFLPGMFADTLPNAPIDQLAVLRLDGDLYESTMDALVNLYPKVSVGGFVIVDDYLIPACKQAVHDYRNEHGIDEPIETVDVTGVYWRR
>merochlorin_1
DLKRALAYMNLIKVTALRQLFYLTESARTGTIVGLKELYGAEGTLYDAVADHQDLNDAWLKLMNTVTANIDPWFFGNIDIPSGARVLDLAGNTGLGAIHTYRHKPSPGLRVTTFDLPEKEAECLANFRAEGLEEHLSFVGGNVFDEIPKGFDVVLIKHFLDMFDKDDVLRILKGVNKSLEVGGQVNILVPVYPEN
>doxorubicin_1
TGERVLDIGCGRGACLFPAAEKVGPQGRVHGIDIAPGMIEEARKEAAERGLRNIALDVMDAE
>spinosad_1
SQNALYLDLLKKVLTNTIYSDRPHPNAWQDNTDYRQAARAKGTDWPTVAHTMIGLERLDNLQHCVEAVLADGVPGDFAETGVWRGGACIFMRAVLQAFGDTGRTVWVVDSFQGMPESSAQDHQADQAMALHEYNDVLGVSLETVRQNFARYGLLDEQVRFLPGWFRDTLPTAPIQELAVLRLDGDLYESTMDSLRNLYPKLSPGGFVIIDDYFLPSCQDAVKGFRAELGITEPIHDIDGTGAYWRRS
>A201A_2_1
LPYPRGGSFLEIGCGSGVIAVTAALSGAARVTAVDINDRAVANTAENARFHGVEDKVTVLHGDLFEAVPPTDRFDVIFWNVPWTWVPED
>etnangien_1
KQLEMRRVIFRHERLESVRKVLDIGCGCGTDLVEVAKRCPHAKAHGFTITRAQADLANRRIGRLGLAERVRVFHADSSKDRFPDTYDLILGFEVTCHIADKTGVFGNISSALSPHGSVLLMDFV
>ansamitocin_1
MLVALTGARLVVEVGTFTGCSTLCLASALPDGGRVITCELSPKWPAIARPHWERAGVADRIEVLVGDAAGSLAGLTGELAGRVDLVFVDADKAGYPRYYELAVELVRPGGLVVVDNTLFSGRVADPAAVDPDTEGVRELNRRIAADDRVQAVLLAHADGMTLARR
>ansamitocin_2
VRHTPLSRALRSTDGLALTRLLTAGWADEAWRGLAEGVRTDTSPLELVHGRPLFDLLAADPAAAAVFHDAVATGPGDPFDEAIRSALDLTGAARVVDVGGGRGRLLAALLREHPVLSGVLFDLPEAVRDAVPELRGDDRVQIRAGDLFADRVGAADVYVLRTVLHVLDDAQAVRALANVRADAPAHARVVVVEALSDDEANRTYAAHSSLRLFVLCGGRERSTAEFAELF
>rapamycin_1
MRLLEGGRIENVLELCGGTGFASRMLAERHSKVQATSIDLSPELTAVGPHKLASRGIDNVTLVEGDVSTLPYPDDSFDTVMSAFGLHEVPTAGRLSAIRESVRVLKPGGRFVI
>rapamycin_2
IENVLELCGGTGFASRMLAERHSKVQATSIDLSPELTAVGPHKLASRGIDNVTLVEGDVSTLPYPDDSFDTVMSAFGLHEVPTAGRLSAIRESVRVLKPGGRFVIVDLD
>resistomcycin_1
DEASRYLVAGRPEYMGGFAAHQNSHFGHFSRLDEAVRTNTSLNQRVLKQGYRDQGAAAGEGREGTGRLIQAMRVSSRLQAGKLAAAVPLAGVRRVVDLGCGSGDYSIALASHHPELRVTALDYPAVTDLARANVREAGLEDRIEVRPADIMADAWPETDAVLLSHVLDGYGPERAAHLVKRIHAHLPDGGRLLVHSHMPALATGLFPAMFGLILLVNTEEGEVRDVDEIRAWV
>resistomcycin_2
EALGLRRAGRVLDLACGGGEWGIALAAADPRAEVTAHDDPVLLGSARARAAEFGVADRFRFVSADFAAPPFADAGFDTVVLAHAGRFAGPTATARLVRECARQLRPGGTLLVADVMRPEPGRPALSRPMLGLSLLVNTADGAVLAAQDYRALM
>nogalamycin_2_1
QRLTEMMTERIEVGPGQRVLDIGCGTGAPAVQLARATGAEVVGITISPEQVRLATAHAEREGVAERVTFRCADASAELPFPADSFDAVWFFESIFHLPDRLTALRRAAEVLRPGGRL
>nogalamycin_2_2
IEVGPGQRVLDIGCGTGAPAVQLARATGAEVVGITISPEQVRLATAHAEREGVAERVTFRCADASAELPFPADSFDAVWFFESIFHLPDRLTALRRAAEVLRPGGRLALTDVLHN
>nogalamycin_2_3
PIELYLDLMSRTVSNTIYEDPQIDPRRYWELLRERDGDGTGPVMDGPGNWSAYDSEGREQGSVWPRDAHTMVGMRRLRNVRECAERVLADGVPGDFMETGVWRGGTCIFMRAVLAAYEVSDRVVWVADSFAGIPAPDLDRYPQDEEARGIESVNEVVGVPLETVRGNFDRYGLLDDQVRFLPGRFCDTLPEAPVERLALLRLDGDLYESTMDALVSMYPKLSPGGYLIVDDYHALDVCKKAVHDYRDQHGIDDPITDIDWSGAYWRKS
>tetracenomycin_1
RTFSATPLSDGLRTGNPDGVLPLVKYNNMELTRRPYDEIMHSVRTGEPAFRRVFGSSFFEHLEANPEAGEFFERFMAHWSRRLVLDGLADQGMERFSRIADLGGGDGWFLAQILRRHPHATGLLMDLPRVAASAGPVLEEAKVADRVTVLPGDFFTDPVPTGYDAYLFKGVLHNWSDERAVTVLRRVREAIGDDDARLLIFDQVMAPENEWDHAKLLDIDMLVLFGGRERVLAEWRQLL
>tetracenomycin_2
EDTYRNSPAADRHLDRRKPGYVGGYARLADTKLFPVWARLTEALRTGEKQVPSQGGFFGGYADPEAARGFLGAMDAVNGGVGHSLAGALDWTEYSSFVDLGGARGNLAAHLHRAHPHLRATCFDLPEMEPFFQEHMKSLETTDQVRFAGGDFFTDPLPRADVFIVGHILHYFGLRQREALIARIHQALTPGGAVLVYDRMIDDDRRSAALSLLGSLNMLLTSDEGREYTPAECVRWL
>salinamide_1
PGQRFRLTVTGARLRADAPGSVRASLLNTDSQRAWLRGADTLRTGLSVFDSALGGAFFDHKNDDAEANTAFLRRMEERAGRLYPNLAAVPDWSDSSVVMDIGGGNGYVLDRVLRAAPHLTGILFERPATVAAVGGSPRLRALGERCRVAEGDFFDRIPADADTHLMCSVLHDWTDEQTVRILRNSRAALRPGGRLLIVEMLVPKDDRWHPGAWSDIGMMVLTGGRERTAEEFTALL
>apoptolidin_1
MQVLPEEARFLALLVLLTGAERILEIGTFTGYSTLSMARALPANGRLVTCDLNPKWVKFAKPYWTRAGVADRIEPRIGDAGTTLDELAAEDPFDLVFIDADKANYPKYYEKSADLLRPGGLIVLDNTLFLGRVIDPSATDPDTNGIREANHLIREDDRMDICVLPLSDGVTLARRK
>apoptolidin_2
ARFLALLVLLTGAERILEIGTFTGYSTLSMARALPANGRLVTCDLNPKWVKFAKPYWTRAGVADRIEPRIGDAGTTLDELAAEDPFDLVFIDADKANYPKYYEKSADLLRPGGLIVL
>apoptolidin_3
ASGQLYLDLLEKVVTNMIYGDAPTPNAWVPETSFTREHRENGLDWPSTAHTMVGLKRIRNVRHCLEQALADGVAGDFIETGVWRGGVCIFARGILKAHGVSDRRVWLADSFEGIPDTGPDGHPMDQEMALHQSNEVLGVSMETVRDNFARYDLLDDQVQFLPGWFEDTLPTAPVEKLAVMRLDGDLYSSTMDALVNLYPKLSPGGFVIIDDYVIPACRKAVEEFRETEGIEDPLEAIDDYSVFWRR
>methylarcyriarubin_1
EGRFALTPLAECLRSDVPGSMRAFATVFGEPWRWRTLGEIVHSVRTGQPAFDKLHGMNLFEYLTRNPEDARLFGEAMTSFSRREFTGASIGEIDAVLQAYDFSAFRRVVDVAGGHGSFIAAALKANPGLGGVLFDVPPVIEDARKYLVAEGLVERCEAVGGSFFDGVPAGGDVYVMKRVIHDWDDARAAAILTQCRRAMAPGGRVALVEMVIPAGNTPFFGKIVDLEMLLIGGRERTASEYRALL
>napyradiomycin_2_1
MEMIKVVTLRQLFYLTDSVRTGTTVGLNKLYGHEGNLYDALAEHKDLREPWARLMNGETAHIDPWFFDNIDVPPGSNVLDLAGNTGLGAIHTCKLKASPGLRVTTFDLPEKEEECLANFRSHGVEEHCSFIGGDVFEEVPKGFDVVLIKHFLPMFDKSDVFKILEGVNRSMDVGGQVHLLVPVFPENIKDSDNYTVDFFPSFFIGCAMGQGGAQKMSTWQKWL
>JBIR_76_1
GVYHNTPETDAHLDRAKPGYGTVAPLLEMANSRLFGIWNHLTDVLRTGLSHDESKDSGQDTYDALYADPARLKQFLASMTGISHRANLRIARQVPWEDYSTVADMGTAQGDLVTQVLLANPHLTGTGFDLPEAEPVFTEYAERHGLGERLRFTGGDFFTDPFPKADVLTFGHILHNWDLDRKKLLLRRAWEALPAGGAVVVYDTLIDDERSENAFALLMSLNMLAVTDGGFGYTGAECQEWM
>endophenazine_1
GYGNTEVGDLLRDRPGSLRDVCLLYGEEFYQAWGHAIETARTGKPGFEVAYGQSLVSYLHDDADAANRFQRVMRAQADNFAFEAVPREIDFSADRHVVDIAGGSGQLLSTVLATAPGARGTLLDLEHTIPIARAHLERTVGCDRVGLVAGDMFTSPLPGEADTYLLSRVLGDWPDDDCVRLLGNVREVMAKHSRLVVIELVVQDGHAGLLAPLWDLHLMVVNGGHQRSFGEYTELA
>cosmomycin_d_1
QPGQRVLDVGCGRGASLFVAAERVGPSGHVLGIDIAPAMVEEARRQAGALGARHVEVRVMDGEHPDLPPASFDVVTGSYSLIFLPDAPAALPRYAALLRPGGR
>cosmomycin_d_2
RPLRPTRLGLLLADGHPAQQRAWLDLNGAVSHADLAFTGLLDVVRTGRPAYSGRYGRPFWEDLSADRALADSFDALMSCDEDLAFEAPADAYDWSAVRHVLDVGGGNGGLLAAIALRAPHVRGTLVELAGPAERARRRFEDAGVDDRVTVAEGDFFKPLPVTADLVLLSFVLLNWSDEDALTILRRCVQALEPGGRILVLDRADVEGDGADRFFSTLLDLRMLTFMGGRVRTRDEVVALA
>cosmomycin_d_3
PGAGRLLDIACGTGGHLRHFTELFAHVEGVELSAPMAEAARAALPGVTVHRGDMRD
>lidamycin_1
GRYTLTPLGRPLCEDHPAGVRAWFDMEGAGRGELSFVDLLHSVRTGKAAFPLRYGRPFWEDLAEDPRRAESFNRLLGQDVATRAPAVVAGFDWASTGHVIDLGGGDGSLLTALLTACPSLRGTVLDLPEAVQRAKESFAVSGLDDRANAVAGSFFDALPAGAGAYVLSLVLHDWDDEASVAILRRCAEAAGQTGSVFVIESTGSAGDAPHTGMDLRMLCIYGAKERRVEEFEELA
>chaxamycin_1
LQQLLQVLNMIKVVMYRQMFYLPESVRTGTLVGLEKLYGFEGNLYEAVAEHPDLRTAWATMMDGVTGQNDPWFLRHVDIPPGAQVLDLAGNTGLGAILTYRRKASPGLRVTTFDLPEKETECLENFRAHGVEEHCSFIGGDVFESIPRGFDVVLIKHFLDMFDKDDVVRILTGVHEALDVGGQVNILVPVYPEDIGDPSSAGV
>pheganomycin_1
GDYANSRVAGTLLVSDGPDAWRHILTGWKEVYFPAFARTGEALRAGTNTALDAHPGTEPTLYGRLAHDPPLEAVFHRAMSAFTLKSVDALVAHEGFADVRALLDVGGGDGTTSTRLTARYPRLTSTVFDIPSVSKIAEQTTAPDFGERVRVHPGDLFADPFPPGHDAVLFSHVLEIFSGEQITALLAKAHSVLPSGGRVFVYGYNVSEDETRGWYSARLSLYLNVLASGQGMAYPARDYERWM
>FK520_1
KVSLRDDEVLSRLRAQTAELPGGGVLPVQAEEGQFLEFLVRLTGARQVLEIGTYTGYSTLCLARGLAPGGRVVTCDVMPKWPEVGERYWEEAGVADRIDVRIGDARTVLTGLLDEAGAGPESFDMVFIDADKAGYPAYYEAALPLVRRGGLIVVDNTLFFGRVADEAVQDPDTVAVRELNAALRDDDRVDLAMLTTADGVTLLRKR
>FK520_2
QFLEFLVRLTGARQVLEIGTYTGYSTLCLARGLAPGGRVVTCDVMPKWPEVGERYWEEAGVADRIDVRIGDAR
>hatomarubigin_1
GRFANSPLADRFLVRGGPEFLGGYLRFCEQELNPAWDGLATSLRTGRPTNRAAVVGNPYDTLYSDPDATDGFLDSMDLLSTPIGLAISRYDWSQYSSFIDVGGARGNFAHQVVTENPHLTAGVFDLPPLEGTFKRHIERLGATASGISFHGGDFFKDKLPKADVIVLGHVLHNWGVEDRVQLLKNVYDAVRPGGAVFVYDPMAGGEQPSLHAVLAGLAMLVWSRGGHEYSVEELHGWL
>geldanamycin_1
ELSLRDDEILAGLRAQTAGLPAAQAMQVMPEEGQLLGLLVRLVGARSVLEIGTFTGYSTLCMARALPADGTLVTCDITAKWPGLGRPFWERADVADRIDVRIGDAKETLAGLRREGREFDLVFIDADKTGYAHYYEESLAMLRRGGLIVLDNTLFFGRVTDPAAQDADTAALREVNKLLREDGRVEISMLTVGDGITLAVK
>geldanamycin_2
LVRLVGARSVLEIGTFTGYSTLCMARALPADGTLVTCDITAKWPGLGRPFW
>chalcomycin_1
MKNVVSNTIYGDHPTFPVGMNVLDKELADRMRPGAEGPDVERGTFDADHRAEGLDVPTVAHTMIGLQRLDNIQRCVERVLQDDVPGDLIETGVWRGGACILMRALLKAHGVEDRTVWLADSFAGVPVTSEDSHPLDRAMEFHHLNWVLSCSEEQVRENFARYGLLDEQVRFLPGMFADTLPTAPIDRLAVLRVDGDLYESTRDALVNLYPKLSVGGFVIVDDYLIPACKQAVHDYRSEHGIDEPIETVDVTGVYWRRE
>chalcomycin_2
AEADLYLDLLKKVVTNMIYEDQTNVAGLITSSSYSAELRSVGEDFPRVAHSMVGLKRLDNLQKCLEDVLRDGVPGDFAETGVWRGGACIFARGVFRAHGVRDRKVWVADSFQGFPKTTEDDHQLDVDIDLGQYNDVLSIPVDVETVKGNFARYGLLDDQVRFLPGWFKDTMPTAPIERLAVLRLDGDSYAATREVLTNLYHKVSDGGYVIVDDYCIPACRQAVHEFRDEHGITDEIHQIDRQGSYWRRS
>chalcomycin_3
VVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDA
>flexirubin_1
RRLLDIGGNTGKWTLACTAYDKDVQVTMFDLPGEIAIAAQRAKDAGVADRVSFHEANILDESLPFPSGFDAIWMSQFLDCFSEEQIVSILKRCGDALTETGTIYILEPFWNRQRFKAAAFSLQQTSLYFTAMANGN
>lazarimide_1
GRFGSTPLLEMLREGVPHSLRDIAIVNGSPAHWLSWGRFPDAVRAGEPQTKAALGSDVWAYFAANPEEFELFSRSMTELSEGLCHEIAELLDTTGVATAVDVGGGNGTLLHALMKSDADLRGVVLDLPGVAPTAIAAADEAGLSDRCEFVGGSFFDTVPEGDLFLLKAVLHNWADDSCVEILTRCREAMRPGGRVVVVEMPLGPVGEPGFAPLLDLNMLAVVPGRERDLAHYDALF
>warkmycin_1
DVPGVIMEFGVLHGRHLAAFTALRSIYEPYNSLRRVIGFDTFTGFPDVSEIDRATPSAVAGRFAVPEDEVDHLRQVLAAHEANEPYGHTQRSFVVQGDVRKTVPQYLQENPETVVALAYIDLDLYEPTLETLHALRPHLAKGSIIAFDELAH
>pradimicin_1
NGVYDNTAVADTYLDAAKPTYTGGFLTMLDHQFAQWGDLTRLLREGGRAYPVDDELDQHDEMHADPARLRRFMSAMDGINQFSGAALADAYDWSAHASFVDLGGARGNLAAELRKAHPHLAAGVMDLPAVQTVFDEHMESLGLTGQVAFTGGDFFNDPLPAAEVLIFGHVLHDWSPELRAALVRRAYEALPSGGELLVYDVMIDDERRTHDFSLLTSLHMMLVSPGGGEYTARDCREWM
>pradimicin_2
DGRFGLTPMAALLRTGTDDSHRDLFMMAAGDLWWRPYGELLETVRTGRPAAELAFGMPFYDYLGTDPAAAGLFDRAMTQVSKGQAKAILGRCSFERYARIADVGGGHGYFLAQVLRSSPRTEGVLLDLPHVVAGAPAVLEKHEVADRVQVVPGSFFDALPTGCDAYLLKAILINWPDADAERILHRVREAIGTDRDARLLVVEPVVPPGDVRDYSKATDIDMLAIIGGRQRTVAEWRRLL
>lactomycin_1
GVFSSTPVTKSLTQDNPHGVFPLIRYNHMELTARPFEDILHSLRTGEPAFKQTFGTTFNDYLEQHPEADRFCDEFQTYWAEQFAEEELDQWELGRFSSIADLGGGDGYFLAQALRRYPEMTAYLFDLPWMAKKGEKIFAEHGVGDRVEIVGGDLLKDPVPAGAACYFVKAVFMRFSDEEAEQALRNIRKAVGDDPEARLLIVDSVLKPGNEWDHGKLLDIDMLVLHGGRKRTLDDWNQLFS
>lactomycin_2
DGRYANSAAAARYLDRTKDAYVGGFFTFMSYALYPAWGRLTGLLRSGSRQEGQDDFGDWYKDLDQVRGFMDAMDSVSAPVTEELARRFDWSAYSTFADLGGARGNLTGHLVRAHPHLRGTTFDVPAIKPLFEEHAARLGVADKVAFQGGDFRTDPLPEADVLIFGHVLHDWDDATRALLVGRATTPCAGGALLIYEELLDDDRRGPARSLLMSLNMRLVRSGGSEYTAAESRVWL
>A_90289_1
NAADAYLDLLKRCLTRYDGRQIFLGPPLTKPRTMEQIERGRFAHQDADTMIGWPRLDNVRHCVETVLREKVPGDLLEAGVWRGGCCVFMRGILKARGVTDRTVWVADSFAGFPEPDTGRYPDDSVYDGPVAREILDGFGYPIAIGLDEVKARFTSYGLLDSQVRFLVGYFADTLPQAPVERLSVLRLDGDMYQSTLESLEYLYPKLSAGGFCIIDDYSLEGCRKAVEHFREAHGITEPIEKIDWTGVFWRRT
>medermycin_1
DDRMPGAASLLDIACGTGAHLARFAERYERVEGVELSEPMLALARTRLPGVPFTLGDMRDF
>ravidomycin_1
RAGRVFALTEVGEALRSDSPTSMRNFARWVGLTADRATWAGLADSVRTGAPAFERMHGQDVWDFMRDHTDVSGVFNDAMTEASRQLIAPVVDAFDFGDIGTLVDVAGGRGALLSAVLKANPKTRGVLYDQPEVVSEARQNFARSGVADRVEIIGGDFFSSVPPAGDAYLLSNVLHDWDDESSLKILANCRAALGDGGRVLLVEAVMTDGARPNPTVSLMDLNMLVLCGGQQRTEAEFADLF
>rebeccamycin_1
LTDEMIALLDVRSGDRVLDVGCGIGKPAVRLATARDVRVTGISISRPQVNQANARATAAGLANRVTFSYADAMDLPFEDASFDAVWALESLHHMP
>clorobiocin_1
GSWLYLNLMKKVLAGTVYEDPAHRQNFSHDDATYREEVRNEGRDWPANAHTMIGIKRLENIQQCVEDVIGNNIPGDLAETGVWRGGACIFMRGILRAHDVRDRTVWVADSFQGIPDVGADGYPGDRRMALHRHNAVLAVSEDEVRRNFRNYDLLDEQVRFLPGWFKDTLPTAPIDALAVLRMDGDLYESTWDTLTNLYPKVSVGGYVIVDDYLMCPPCKDAVDEYRARFDIADELIRIDRDGVYWQRT
>prodigiosin_3_1
LYHLPAAHRAFLLSDEPQWLGWLGRHIDTFLYPLWGELKTAVRNDAHQRRTVFGDDRSWFDILYQNPDDVADFQEFLGKFAAPFIAGFVRDYDFSQHRAFLDIGSGIGSLPMAIADAYPGIALAICELPQASAFLRDKLTLQGYGERIDVVEGDVISGDLPIGGYDLIHLGWMLHDYAPETQLTILRNIYRAMPAGGRFIASETPLNEDKSGPEFTALLSLNMLVSTDGGIESSAQEY
>prodigiosin_2_1
GLYHLPQEHRAFLVSDEPQWLGWLGRHIDTFLYPLWGELKAAVENDTHQRQTVFGDDRSWFDILYQNPDDVTDFQEFLGKFAAPFIDGFIQDYDFSQHQAFLDIGSGIGSLPIAVANAYSGVNLAICELPQTSTFLRDKLVQQGYGQRIQVLEGDVISGDLPIGDYDLIHLGWMLHDYAPETQLIILKNIYDAMPVGGRFIASETPLNADKSGPEFTALLSLNMLVSTDGGIESSPQEY
>shinorine_1
TTVRPLEQEMLSGHIEGQTLKMFVHMTKAKKVLEIGMFTGYSALAMAEALPEDGLLVACEVDPYAAEIGQKAFQQSPHGGKIRVELDAALATLDKLAEAGESFDLVFIDADKKEYVAYFHKLLGSSLLAPDGFICVDNTLLQGEVYLPAEERSVNGEAIAQFNHTVAIDPRVEQVLLPLRDGLTIIRRI
>prodigiosin_4_1
GDAYSLAPGAAPYLVSQSPQWLGWLGRHIDAFLYPLWSYTAQAVRDDKDQREAVFGDKRSWFDILYQNPSDVTDFQEFLGIFAKPFIDGMVEGVDFSAYSRFMDIGSGVGSLPVAVAEACPHLEIAICELPKAACYVRDKIMSGEFADRIDVVEGDVIAGTIPQQEYDLIHLGWMLHDYAPDTQLQILRNIYDALPAGGVFMASETPLDEDESGPLFTSLLSINMLVSTDGGVESTAQQY
>furaquinocin_a_1
RYRNTPEASLYLVDGKPTSLSSFARLKLKHMGGLTALPDVVRAGGPIQHATTEVADNPHWEEIVPAIAAQSVPAAQVAAQALGLAEAGPVSILDVGGGSGVYSAIWLAANPAARSTQLDWEPINVIARRLVAEQGVGDRFTTVAGDFHTTDFGTGEYDIALYSHIAHQEAPEDNIAVLSRLREALKPGGALVVCDYVVEDDRSGPAFPLIFAAEMLLKSKQGGTWRRSDYHNWL
>furaquinocin_a_2
LKRALAYMNMIKVVALRQLFHLTESAQTGTLVGLKELYGVTEGTLYGAVAEHRDLRDAWSNLMNTVTANIDPWFFGNVDVPAGARVLDLAGNTGLGAIHTVAHKASPGLQVTTFDLPEKEQEALANFKAHGVAESCSFIGGDVFDGVPKGFDIVLIKHFLDMFDKDDVIRILQGVNQALEVGGQVNIMVPVYPEDITDTD
>furaquinocin_a_3
LQRALTFMGMIKTGMLRQLYHLADSVSSGSVVGLKELYGFDGTMFEAAAEVAEVRAAWGPLAQNETASVYPWFFRSFDVPAGARVLDVRGGNGLGAIMTCQTKASPGLRVTTLDRPALEAECLRNCEAHGVAEQCSCVGGEVLDALPGGFDVLLLKHFVDMYDKDDVLTMFRNAHRALEPGGQIVVLAPVYPEDVRDADDYQADFF
>chortetracycline_1
DGRYVHTGASRLLREDTPRSLKDMVLWGTEPWTWELWGHLDEAVRTGKAVFPELHGMDFFDHLHAHSPESAAVFDRAMTQSSRLSALALADRLDLGGVGTVVDIAGGQGHVLATLLERNPGLRGTLLDLPEVVSGADARLQPGGALAGRATLLGGDCRREIPVQADVYLLKNILEWDDESTVLTLRNVVRAAAPGSRVIVVENLVDGSPELRFTTAMDLLLLLNVGGRKHTRAGLVSLI
>chortetracycline_2
PGPTYLGGTARQHARLHYHAWAQLTDALRDGKAKSAVAAQGQLAYPKQYEDLDRARQIMLHMDAHNGFTADELARAIDWSRYTSFVDVGGGRGNVASRIVTAHPHLRGGVFDLPALRPLFEELVVSAGTADRVDFHGGDFFATDLPEADVVIFGHVLPDWPVGDRRELLRRAHKAVRPGGLVVLYDAMIDPEERDPEVLLQRINHTMIRDEAGAYSLQEARAYL
>cervnimycin_1
EVFALTELAEGLRGDLPDNVRDAVLLDGSERFNRAFTGIGHSVRTGKPGFDHVHGMSFWEYLEQDTQALHTFDAAMTGISRRLGRHYLERHDFGRPSRIADVGGGRGYFLASLLKRYPEATGVLFDRPSVVTEAHALLRERAVADRVDVVGGDFFTDDLPTGCDTYVLKTVLHDWPDDAAETILRRVRAAVGDSGARLLILEQVVAPMNTWDPAKFLDIDMMVIMGGRERNLQEWRRLL
>marinophenazines_1
DGRFALTPLAQLLRSDVPGSMRSYVEMHGHDIFVRSATGLAQAVRTGGNPFEAEFGMPFYQYLFGNRELGMQFDASMASFSEALSDQVAAAYDFGSARSVVDVGGGRGGQLLAVLRRNAHLEGTLMDREPVVAGHVLDVPELTGRWRAVGGDFFSAVPEGGDVYILKHVLASWPDDQCVRILEVCRDAMPDDGRLLMVNALVPEGNEPHPAKDVDMVMLTVLNGKGRTQAEYEDLM
>nocathiacin_2_1
AELRAGERVLDLGSGGGIDVLLSARRVGPTGKAYGVDMTDEMLALALANKASAGADNVEFLKG
>xantholipin_1
GRYRNSEAAQRYLVRGANYAGGFLEGANFVLYPAWGRLTQALRSGTPQAEGDFEAMLSDPAAQRVFLTMQDSLSAPLVPYLLGALEWGGWSTLTDVGGARGNLAGLLLRAQPHLTGRVFDRPQNAGPCAEHAQTLGVADRLSFTGGDFFADELPEADVVVIGHVLADFSLEERKLLIEKAYRAVRPGGALLVYDPMPGDKPDLASLVASLHMLVMTPAGAGYHPGDCG
>xantholipin_2
AQQFLVPGDEGYLGGFLKIAGQVMYPAWDKLGEALRTGAPQAATYTGEDMFGELYDSDEKKDGLVGMAEDASRPLIPALTESFGWAKYNSVLELGGCRGNVLAGLVKAHPHLDACVFDLPQLEGDFTAHMANLGMAGKVRYHGGDFFADALPQADVLMIGHALVDWNDEQRRQLVKNTFAAVRPGGAFLVWDPVIVDDDESYLRNLIRSLNLQLMTPHGKGYRFEQCAEW
>xantholipin_3
YRNAKGADTYLVRGERTWVGGFLERSNRNLYPAWGRLGEALRTGEQQSGSHFDVVVQNPHILKQFVHMMDALTHVVGPELVGKFDWSNSKSVLDVGGARGNLCSIIVKNQPHLEGHVFDLPPMKPLFDEHVESYGLTGKVHFHGGSFFTDPLPVKADVVTMGHVLHDWDRQQRGELVAKAFDAVNPGGALIVYDRMLDDEPNHVENLVISLDMLLVTDGGSEYPTSEL
>kijanimicin_1
SKGIMPSPGADTMVSQERLDNIHHAAATVIREGVPGDFIETGVWRGGSCILMRAALTAYGDRTRKVWVADSFDGFPPPTDKYPSDPWQGRSQDIIGTLGVSLKVTFEEVKERFARYGLLDERVEFLTGFFEHTLPSAPIDRLAILRLDGDLYQSTYEALEALYPKLSVGGYCIIDDYFYTMCSKAVDDYRRKHNIDEPIEAVDWTCVQWRK
